149 related articles for article (PubMed ID: 29625321)
1. Secreted Wnt antagonists in leukemia: A road yet to be paved.
Pehlivan M; Çalışkan C; Yüce Z; Sercan HO
Leuk Res; 2018 Jun; 69():24-30. PubMed ID: 29625321
[TBL] [Abstract][Full Text] [Related]
2. Wnt Signaling in Hematological Malignancies.
Grainger S; Traver D; Willert K
Prog Mol Biol Transl Sci; 2018 Jan; 153():321-341. PubMed ID: 29389522
[TBL] [Abstract][Full Text] [Related]
3. Normal hematopoiesis and hematologic malignancies: role of canonical Wnt signaling pathway and stromal microenvironment.
Seke Etet PF; Vecchio L; Bogne Kamga P; Nchiwan Nukenine E; Krampera M; Nwabo Kamdje AH
Biochim Biophys Acta; 2013 Jan; 1835(1):1-10. PubMed ID: 22982245
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic potency of Wnt signaling antagonists in the pathogenesis of prostate cancer, current status and perspectives.
Pashirzad M; Shafiee M; Khazaei M; Fiuji H; Ryzhikov M; Soleimanpour S; Hesari A; Avan A; Hassanian SM
J Cell Physiol; 2019 Feb; 234(2):1237-1247. PubMed ID: 30191954
[TBL] [Abstract][Full Text] [Related]
5. [Wnt/beta-catenin signal pathway and malignant hematological disease -- review].
Wang YX; Zhang JH; Gu ZW
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):234-7. PubMed ID: 19236787
[TBL] [Abstract][Full Text] [Related]
6. Wnt Signaling and Drug Resistance in Cancer.
Zhong Z; Virshup DM
Mol Pharmacol; 2020 Feb; 97(2):72-89. PubMed ID: 31787618
[TBL] [Abstract][Full Text] [Related]
7. [Antagonists of Wnt pathway].
Kinoshita Y; Fukumoto S
Clin Calcium; 2013 Jun; 23(6):817-23. PubMed ID: 23719493
[TBL] [Abstract][Full Text] [Related]
8. Wnt signaling in leukemias and myeloma: T-cell factors are in control.
Tiemessen MM; Staal FJ
Future Oncol; 2013 Nov; 9(11):1757-72. PubMed ID: 24156335
[TBL] [Abstract][Full Text] [Related]
9. Targeting Wnt signaling pseudokinases in hematological cancers.
Karvonen H; Perttilä R; Niininen W; Barker H; Ungureanu D
Eur J Haematol; 2018 Oct; 101(4):457-465. PubMed ID: 29989208
[TBL] [Abstract][Full Text] [Related]
10. Wnt/beta-catenin pathway: modulating anticancer immune response.
Pai SG; Carneiro BA; Mota JM; Costa R; Leite CA; Barroso-Sousa R; Kaplan JB; Chae YK; Giles FJ
J Hematol Oncol; 2017 May; 10(1):101. PubMed ID: 28476164
[TBL] [Abstract][Full Text] [Related]
11. Growth inhibition of imatinib-resistant CML cells with the T315I mutation and hypoxia-adaptation by AV65--a novel Wnt/β-catenin signaling inhibitor.
Nagao R; Ashihara E; Kimura S; Strovel JW; Yao H; Takeuchi M; Tanaka R; Hayashi Y; Hirai H; Padia J; Strand K; Maekawa T
Cancer Lett; 2011 Dec; 312(1):91-100. PubMed ID: 21906872
[TBL] [Abstract][Full Text] [Related]
12. Amide-linked local anesthetics preferentially target leukemia stem cell through inhibition of Wnt/β-catenin.
Ni J; Xie T; Xiao M; Xiang W; Wang L
Biochem Biophys Res Commun; 2018 Sep; 503(2):956-962. PubMed ID: 29932919
[TBL] [Abstract][Full Text] [Related]
13. Wnt signaling pathways in urological cancers: past decades and still growing.
Majid S; Saini S; Dahiya R
Mol Cancer; 2012 Feb; 11():7. PubMed ID: 22325146
[TBL] [Abstract][Full Text] [Related]
14. Role of WNT signaling in normal and malignant hematopoiesis.
Khan NI; Bendall LJ
Histol Histopathol; 2006 Jul; 21(7):761-74. PubMed ID: 16598675
[TBL] [Abstract][Full Text] [Related]
15. The involvement of noncanonical Wnt signaling in cancers.
Chen Y; Chen Z; Tang Y; Xiao Q
Biomed Pharmacother; 2021 Jan; 133():110946. PubMed ID: 33212376
[TBL] [Abstract][Full Text] [Related]
16. Can we safely target the WNT pathway?
Kahn M
Nat Rev Drug Discov; 2014 Jul; 13(7):513-32. PubMed ID: 24981364
[TBL] [Abstract][Full Text] [Related]
17. aBETting therapeutic resistance by Wnt signaling.
Engelke CG; Chinnaiyan AM
Cell Res; 2015 Nov; 25(11):1187-8. PubMed ID: 26516144
[TBL] [Abstract][Full Text] [Related]
18. Chemical Disruption of Wnt-dependent Cell Fate Decision-making Mechanisms in Cancer and Regenerative Medicine.
Lum L; Chen C
Curr Med Chem; 2015; 22(35):4091-103. PubMed ID: 26310918
[TBL] [Abstract][Full Text] [Related]
19. Bisleuconothine A, a bisindole alkaloid, inhibits colorectal cancer cell in vitro and in vivo targeting Wnt signaling.
Kong LM; Feng T; Wang YY; Li XY; Ye ZN; An T; Qing C; Luo XD; Li Y
Oncotarget; 2016 Mar; 7(9):10203-14. PubMed ID: 26862734
[TBL] [Abstract][Full Text] [Related]
20. Secreted frizzled related proteins: Implications in cancers.
Surana R; Sikka S; Cai W; Shin EM; Warrier SR; Tan HJ; Arfuso F; Fox SA; Dharmarajan AM; Kumar AP
Biochim Biophys Acta; 2014 Jan; 1845(1):53-65. PubMed ID: 24316024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
